Evidence map›Paper›PMID 21158892›Full record

ReviewClinical endocrinology2011

PCOS Forum: research in polycystic ovary syndrome today and tomorrow.

Renato Pasquali, Elisabet Stener-Victorin, Bulent O Yildiz, Antoni J Duleba, Kathleen Hoeger, Helen Mason, Roy Homburg, Theresa Hickey, Steve Franks, Juha S Tapanainen and 4 more

Open access · greenAbstract readReview
In one paragraph

Review in Clinical endocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
11.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 185 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Inflammatory Responses of Women with Polycystic Ovary SyndromeInternational journal of molecular and cellular medicine · 2023
    Article
  8. Article
  9. Review
  10. AssociationMolecular syndromology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Contemporary approaches to the management of polycystic ovary syndrome.Therapeutic advances in endocrinology and metabolism · 2018
    Review
  18. Investigation of Therapeutic Effects of Erdosteine on Polycystic Ovary Syndrome in a Rat Model.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2018
    Article
  19. Effect of chamomile capsule on lipid- and hormonal-related parameters among women of reproductive age with polycystic ovary syndrome.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 9 countries.

Renato PasqualiDivision of Endocrinology, St.Orsola-Malpighi Hospital, University Alma Mater Studiorum of Bologna, Italy.
Elisabet Stener-Victorin
Bulent O Yildiz
Antoni J Duleba
Kathleen Hoeger
Helen Mason
Roy Homburg
Theresa Hickey
Steve Franks
Juha S Tapanainen
Adam Balen
David H Abbott
Evanthia Diamanti-Kandarakis
Richard S Legro
Barzilai Medical Center · ILFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine · CNHacettepe University · TRHammersmith Hospital · GBLeeds General Infirmary · GBOulu University Hospital · FIPenn State Milton S. Hershey Medical Center · USSotiria General Hospital · GRSt George's, University of London · GBUniversity of Adelaide · AUUniversity of California, Davis · USUniversity of Wisconsin–Madison · US

Funding

Translational Research in Polycystic Ovary SyndromeU54HD034449 · NICHD · VIRGINIA COMMONWEALTH UNIVERSITY · PI NESTLER, JOHN E · 1997 to 2012
$15.0M
COOPERATIVE MULTICENTER REPRODUCTIVE MEDICINE NETWORKU10HD038992 · NICHD · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LEGRO, RICHARD S. · 2000 to 2017
$5.0M
Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS WomenR01HD056510 · NICHD · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LEGRO, RICHARD S. · 2008 to 2012
$3.1M
NICHD NIH HHS R01 HD056510NICHD NIH HHS R01HD056510NICHD NIH HHS U10 HD038992NICHD NIH HHS U10 HD 38992NICHD NIH HHS U54 HD034449
6 · The paper itself

Abstract

objectiveTo summarize promising areas of investigation into polycystic ovary syndrome (PCOS) and to stimulate further research in this area.

designSummary of a conference held by international researchers in the field of polycystic ovary syndrome.

resultsPotential areas of further research activity include the analysis of predisposing conditions that increase the risk of PCOS, particularly genetic background and environmental factors, such as endocrine disruptors and lifestyle. The concept that androgen excess may contribute to insulin resistance needs to be re-examined from a developmental perspective, since animal studies have supported the hypothesis that early exposure to modest androgen excess is associated with insulin resistance. Defining alterations of steroidogenesis in PCOS should quantify ovarian, adrenal and extraglandular contribution, as well as clearly define blood reference levels by some universal standard. Intraovarian regulation of follicle development and mechanisms of follicle arrest should be further elucidated. Finally, PCOS status is expected to have long-term consequences in women, specifically the development of type 2 diabetes, cardiovascular diseases and hormone dependent cancers. Identifying susceptible individuals through genomic and proteomic approaches would help to individualize therapy and prevention.

conclusionsThere are several intriguing areas for future research in PCOS. A potential limitation of our review is that we focused selectively on areas we viewed as the most controversial.

Indexed as

AnimalsFemaleGenetic Predisposition to DiseaseHumansHyperandrogenismOvaryPolycystic Ovary SyndromeSympathetic Nervous System

Identifiers

PMID21158892
PMCPMC3742326
OpenAlexW1906653047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.